Skip to main content
Top
Published in: Cancer Causes & Control 5/2009

01-07-2009 | Original Paper

Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women

Authors: Xiao-Rong Wang, Ignatius T. S. Yu, Yuk Lan Chiu, Hong Qiu, Zhenming Fu, William Goggins, Joseph S. K. Au, Lap-Ah Tse, Tze-Wai Wong

Published in: Cancer Causes & Control | Issue 5/2009

Login to get access

Abstract

Chinese women in Hong Kong have among the highest incidence and mortality of lung cancer in the world, in spite of a low prevalence of smoking. We carried out this population-based case–control study to evaluate the associations of previous lung disease and family cancer history with the occurrence of lung cancer among them. We selected 212 cases that were newly diagnosed with primary lung cancer, and randomly sampled 292 controls from the community, frequency matched by age group. All the cases and controls were lifetime nonsmokers. We estimated the main effects of preexisting asthma, pulmonary tuberculosis, pneumonia, chronic bronchitis, and family lung/all cancer history, using unconditional logistic regression, accounting for various potential risk factors and confounders. All of the previous lung diseases, except chronic bronchitis, were related to an elevated risk for lung cancer, and the association with asthma was significant. Those who had more than one previous lung disease tended to be at higher risk than those with only one of them. Positive family history of any cancer was associated with over 2-fold risk than negative family history. The joint effect of positive history of previous pulmonary diseases and positive family cancer history appeared to be additive, indicating the two factors acted independently. The results support an etiological link of preexisting lung disease and family cancer history to the risk of lung cancer.
Literature
1.
go back to reference Hong Kong Cancer Registry (2002) Cancer Stat 2000. Hospital Authority, Hong Kong Hong Kong Cancer Registry (2002) Cancer Stat 2000. Hospital Authority, Hong Kong
2.
go back to reference International Agency for Research on Cancer (1986) IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking, vol 38. International Agency for Research on Cancer, Lyon International Agency for Research on Cancer (1986) IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking, vol 38. International Agency for Research on Cancer, Lyon
5.
go back to reference US Environmental Protection Agency (1992) Respiratory health effects of passive smoking: lung cancer and other disorders. Washington, DC, EPA/600/6-90/006F US Environmental Protection Agency (1992) Respiratory health effects of passive smoking: lung cancer and other disorders. Washington, DC, EPA/600/6-90/006F
7.
go back to reference Beckett WS (1993) Epidemiology and etiology of lung cancer. Clin Chest Med 14:1–15PubMed Beckett WS (1993) Epidemiology and etiology of lung cancer. Clin Chest Med 14:1–15PubMed
10.
go back to reference Liu Q, Sasco AJ, Riboli E, Hu MX (1993) Indoor air pollution and lung cancer in Guangzhou, People’s Republic of China. Am J Epidemiol 137:145–154PubMed Liu Q, Sasco AJ, Riboli E, Hu MX (1993) Indoor air pollution and lung cancer in Guangzhou, People’s Republic of China. Am J Epidemiol 137:145–154PubMed
12.
go back to reference Alberg AJ, Samet JM (2005) Epidemiology of lung cancer. In: Sadler MJ, Caballero B, Strain JJ (eds) Encyclopedia of human nutrition. Academic Press, London, pp 272–284 Alberg AJ, Samet JM (2005) Epidemiology of lung cancer. In: Sadler MJ, Caballero B, Strain JJ (eds) Encyclopedia of human nutrition. Academic Press, London, pp 272–284
13.
go back to reference Mayne ST, Buenconsejo J, Janerich DT (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149:13–20PubMed Mayne ST, Buenconsejo J, Janerich DT (1999) Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 149:13–20PubMed
17.
21.
go back to reference Lam TH, Kung IT, Wong CM et al (1987) Smoking, passive smoking and histological types in lung cancer in Hong Kong Chinese women. Br J Cancer 56:673–678PubMed Lam TH, Kung IT, Wong CM et al (1987) Smoking, passive smoking and histological types in lung cancer in Hong Kong Chinese women. Br J Cancer 56:673–678PubMed
25.
go back to reference Alavanja MC, Brownson RC, Boice JD Jr, Hock E (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 136:623–632PubMed Alavanja MC, Brownson RC, Boice JD Jr, Hock E (1992) Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 136:623–632PubMed
26.
go back to reference Wu AH, Fontham ET, Reynolds P et al (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141:1023–1032PubMed Wu AH, Fontham ET, Reynolds P et al (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141:1023–1032PubMed
29.
go back to reference Brown DW, Young KE, Anda RF et al. (2005) Asthma and risk of death from lung cancer: NHANES II mortality study. J Asthma 42:597–600 Brown DW, Young KE, Anda RF et al. (2005) Asthma and risk of death from lung cancer: NHANES II mortality study. J Asthma 42:597–600
31.
go back to reference Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer in humans. J Natl Cancer Inst 30:289–312PubMed Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer in humans. J Natl Cancer Inst 30:289–312PubMed
Metadata
Title
Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women
Authors
Xiao-Rong Wang
Ignatius T. S. Yu
Yuk Lan Chiu
Hong Qiu
Zhenming Fu
William Goggins
Joseph S. K. Au
Lap-Ah Tse
Tze-Wai Wong
Publication date
01-07-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 5/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9289-4

Other articles of this Issue 5/2009

Cancer Causes & Control 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine